Aristides Capital LLC Veru Inc. Transaction History

Aristides Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.35 - $15.85 $48,628 - $177,187	-11,179 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $203,198 - $286,264	-44,659 Reduced 79.98%	11,179 $54,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $263,041 - $434,532	44,659 Added 399.49%	55,838 $329,000
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $80,935 - $125,204	11,179 New	11,179 $90,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Aristides Capital LLC with notifications on news.